Aditi Sapre LinkedIn
"A well-designed clinical trial is the cornerstone of medical progress, sculpted through careful participant selection, randomization, and blinding. It guides us towards informed medical decisions and advances the frontier of healthcare knowledge."
ADITI SAPRE, Ph.D., director of biostatistics at Organon, has over 25 years of experience as a biostatistician in the pharmaceutical industry focused on providing statistical support to late-stage clinical development specifically phase II-V clinical studies. Previously she was principal scientist at Merck Research Laboratories and her experience includes strategic design and decision making, timely and quality statistical analysis to regulatory submissions across multiple therapeutic areas, including vaccines, diabetes, cardiovascular, and pulmonary. She received her undergraduate degree in Statistics from the University of Mumbai and her doctorate in Biostatistics from Louisiana State University with a minor in Epidemiology.